Acetazolamide for Treatment Resistant Schizophrenia
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Schizophrenia
Related studies linked through entity extraction aliases.
Feasibility of a Novel Process-based Treatment for Patients With Psychosis
- Status
- COMPLETED
- Phase
- NA
Examining tDCS Effect on Cannabis Use Disorder in Patients With Schizophrenia
- Status
- RECRUITING
- Phase
- NA
RCT of tDCS Combined With Cognitive Training in Schizophrenia
- Status
- COMPLETED
- Phase
- NA
Feasibility Electrical Stimulation Study for Visual Hallucinations
- Status
- COMPLETED
- Phase
- NA
Study of the Impact on the Therapeutic Alliance of a Short Initial Psychoeducation Programme in Patients With Early Schizophrenia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Clinical Trial Study to Determine the Effect of an Investigational Drug (SEP-363856) Has on the Way That the Drug Metformin Travels Through the Body in People With Schizophrenia.
- Status
- COMPLETED
- Phase
- PHASE1
CONNEX-3: A Study to Test Whether Iclepertin Improves Learning and Memory in People With Schizophrenia
- Status
- COMPLETED
- Phase
- PHASE3
Developing Dual-channel Transcranial Alternating Current Stimulations Targeting Negative Symptoms in Schizophrenia
- Status
- COMPLETED
- Phase
- NA
Memantine Augmentation of Targeted Cognitive Training in Schizophrenia
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Targeting Individual Alpha Frequencies to Enhance Perceptual Timing
- Status
- COMPLETED
- Phase
- N/A
Bioequivalence Study in Patients With Schizophrenia by Using Clozaril 100 mg Tablet (Clozapine) and WID-CLZ18
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1)
- Status
- COMPLETED
- Phase
- PHASE3
A Single Ascending Dose Study Of CY150112 After Single Oral Administration in Healthy Chinese Subjects
- Status
- UNKNOWN
- Phase
- PHASE1
A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia, Followed by an Open-label Extension Phase
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Safety, Biomarker Study of RL-007 in Subjects With Schizophrenia
- Status
- COMPLETED
- Phase
- PHASE2
The Effect of Psychoeducation Based on Uncertainty In Illness Theory On Schizophrenia Caregivers
- Status
- COMPLETED
- Phase
- NA
An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5)
- Status
- COMPLETED
- Phase
- PHASE3
Medial-prefrontal Enhancement During Schizophrenia Systems Imaging
- Status
- RECRUITING
- Phase
- NA